Dr Stephen Dale Smith, MD in Westwood, KS - Pediatrics

Dr Stephen Dale Smith, MD is a Pediatrics - Pediatric Hematology-oncology physician based in Westwood, Kansas. Dr Stephen Dale Smith is licensed to practice in Kansas (license number 04-17361) and his current practice location is 2330 Shawnee Mission Parkway, Westwood, Kansas. He can be reached at his office (for appointments etc.) via phone at (913) 588-6340.

NPI number for Dr Stephen Dale Smith is 1760495402 and his current mailing address is 3901 Rainbow Blvd, University Of Kansas Medical Center, Kansas City, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1760495402.

Contact Information

	Dr Stephen Dale Smith, MD
	2330 Shawnee Mission Parkway, Westwood, KS 66205
	(913) 588-6340
	(913) 588-2245

Physician's Profile

Full Name	Dr Stephen Dale Smith
Gender	Male
Speciality	Pediatrics - Pediatric Hematology-oncology
Location	2330 Shawnee Mission Parkway, Westwood, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1760495402
Provider Enumeration Date: 08/14/2006
Last Update Date: 03/27/2012

Medical Identifiers

Medical identifiers for Dr Stephen Dale Smith such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1760495402	NPI	-	NPPES
100287090B	Medicaid	KS
036079523	Medicaid	IL

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2080P0207X	Pediatrics - Pediatric Hematology-oncology	036079523 (Illinois)	Secondary
2080P0207X	Pediatrics - Pediatric Hematology-oncology	04-17361 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stephen Dale Smith is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Stephen Dale Smith, MD 3901 Rainbow Blvd, University Of Kansas Medical Center, Kansas City, KS 66160 Ph: (913) 588-6340	Dr Stephen Dale Smith, MD 2330 Shawnee Mission Parkway, Westwood, KS 66205 Ph: (913) 588-6340

News Archive

Neuroscientists prevent memory loss in fruit flies by blocking activity of PI3 kinase signaling protein

By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans. The study also resolves a long-standing controversy about the role of this protein, PI3 kinase, which was previously thought to have a protective function against the disease.

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its proprietary Locked Nucleic Acid (LNA) technology, holds promise as a novel treatment for patients infected with the Hepatitis C virus (HCV).

Warfarin treatment after aortic valve replacement reduces risk of cardiovascular death

Although current guidelines recommend 3 months of anticoagulation treatment after bioprosthetic aortic valve replacement surgery, a study that included more than 4,000 patients found that patients who had warfarin therapy continued between 3 and 6 months after surgery had a lower rate of cardiovascular death, according to a study in the November 28 issue of JAMA.

Drebrin autoantibodies trigger epilepsy

Certain forms of epilepsy are accompanied by inflammation of important brain regions. Researchers at the University of Bonn have now identified a mechanism that explains this link.

Johns Hopkins scientists use gene-based tests to distinguish precancerous cysts from harmless cysts

In a "look-back" analysis of data stored on 130 patients with pancreatic cysts, scientists at Johns Hopkins have used gene-based tests and a fixed set of clinical criteria to more accurately distinguish precancerous cysts from those less likely to do harm. The findings may eventually help some patients in real time safely avoid surgery to remove harmless cysts.

Dr Stephen Dale Smith, MD - Pediatrics in Westwood, KS